丹麦研究发现,在肥胖成年人中,塞马格卢提德可减少大量饮酒. Danish study finds semaglutide reduces heavy drinking in obese adults with alcohol use disorder.

丹麦对108名患有酒精使用障碍的肥胖成年人进行的一项研究发现,减肥药物西马格卢提德与安慰剂相比显著减少了大量饮酒日和酒精消费. A Danish study of 108 obese adults with alcohol use disorder found that the weight-loss drug semaglutide significantly reduced heavy drinking days and alcohol consumption compared to a placebo. 服用西马格卢提德的参与者报告说,他们对食欲的渴望减少了,但研究人员强调需要进一步进行研究以确认长期影响. Participants taking semaglutide reported fewer cravings, though researchers emphasize the need for further studies to confirm long-term effects.